QualityStocksNewsBreaks Archives - Page 447 of 1575

TuesdayMar 28, 2023 11:49 am

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Partners with Darkbeam to Provide Intelligence-Led Cyber Risk-Management Options

SideChannel (OTCQB: SDCH), a provider of cybersecurity services announced a strategic partnership with London-based Darkbeam, a leading provider of cyber-risk and threat-management capabilities. The partnership is designed to help businesses build intelligence-led, cyber-risk management programs that covering their own operations as well as those of their entire supply chain, enable advisories to inform clients on cyber-risk management during mergers and acquisitions processes, and assist insurance underwriters to better understand their exposure to clients' cyber risks. According to the announcement, the collaboration will combine SideChannel's extensive cybersecurity expertise with Darkbeam's advanced Cyber Risk Management platform; together the companies are focused on making…

MondayMar 27, 2023 12:59 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Eyes Successful Results of Its Preorder Strategy

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, today announced the success of its preorder sales initiative. According to the update, the company has received commitments for the first production target batch of five systems. Since implementation of the initiative, FuelPositive’s team has been systematically vetting each inquiry to select the best end-users for one of the company’s FP300 systems, providing a dedicated solution to fit each individual requirement. “We are excited to see such positive results from our preorder sales initiative, and we are grateful for the confidence and support of our customers from around the world,”…

MondayMar 27, 2023 12:28 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host Town Hall Marathon

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced its plans to hold 10 Town Halls during the first 10 days of April 2023. The event series is in celebration of Knightscope’s 10 year anniversary and following the filing of its 10-K annual report. The announcement reads, “Similar to numerous prior Town Halls hosted by the company over the years, Knightscope’s Chairman and CEO, William Santana Li, will be available to answer questions from supporters, investors and analysts in an intimate online forum with no moderator. In order to accommodate busy…

MondayMar 27, 2023 11:46 am

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Could Play Key Role in Farming Future

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, has noted that its innovative controlled environment farms could be key to feeding the world, which is projected to reach a population of 10 billion by the next generation. Such an increase would require a 70% increase in global food production, the United Nations has forecast. With that as a backdrop, controlled environment agriculture offers a potential solution because of its ability to produce high yields in small spaces using little water and no soil. Controlled environment agriculture includes indoor and vertical farming practices…

MondayMar 27, 2023 10:58 am

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application titled “Methods and Compositions for Pain Management.” The methods and compositions described in the patent application can be used in ameliorating pain, including chronic pain such as fibromyalgia, which is a chronic condition that occurs in approximately 2% of the United States general population. Fibromyalgia is the initial target indication for the company’s drug, SP-26. “This provisional patent application supports our multi-pronged strategy for advancing SP-26 into the clinic,” said Silo Pharma CEO…

FridayMar 24, 2023 2:45 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Board-Approved Action to Regain Compliance with NASDAQ Market Requirements

Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, has announced a reverse share split. The move is designed to increase the market price per share of the company’s ordinary share, thereby resulting in Freight Technologies regaining compliance with NASDAQ’s minimum bid price requirement and maintaining its NASDAQ Capital Market listing. FRGT board of directors approved the 10:1 reverse split on March 3, 2023; the split will be effective on or around March 24, 2023. According to the announcement, the company’s ordinary shares will continue to trade on NASDAQ under the symbol FRGT but will trade under a new…

FridayMar 24, 2023 12:33 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Efforts to Boost Commercial Prospects ‘Paying off in Spades’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology. Lexaria is continuing and/or initiating discussions with several larger companies in Europe and North America regarding the licensed use of its technology for both consumer and pharmaceutical sectors. “The materialization of such partnerships hinges on a number of must-haves. Firstly, there must be a tangible product that draws larger companies. Secondly, The decision of whether or not to invest, and the scale of any investment, is based on how well the technologies that form the core of a company have been protected.…

FridayMar 24, 2023 12:18 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Holds Potential to Combat New COVID-19 Variants

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. “BiondVax is seeing convincingly positive outcomes for preventing and arresting disease in COVID patients during an ongoing preclinical in vivo study, even as continually evolving variants are shutting down emergency-use authorization (‘EUA’)-approved avenues of treatment that may no longer be effective… However, BiondVax’s development of a nanosized antibody (‘NanoAb’), that to date has shown neutralization of all relevant Omicron subvariants, is generating excitement as a potential superior prophylactic approach to COVID prevention… At-risk groups, such…

FridayMar 24, 2023 11:58 am

QualityStocksNewsBreaks – Why Progressive Care Inc. (RXMD) Is ‘One to Watch’

Progressive Care (OTCQB: RXMD) is an organization based in Florida that, through its wholly owned subsidiaries PharmcoRx Pharmacy and ClearMetrX, offers personalized care services and technology to support the managed health care industries. “Progressive Care offers a wide range of innovative solutions to address the dispensing, delivery, dosing and reimbursement of clinically intensive, high-cost drugs. Progressive Care currently operates four pharmacies in Florida, which generate the majority of its revenue,” reads a recent article. “Pharmacy revenue is derived from dispensing medications, third-party administrative services to 340B-covered entities, and medication therapy management (‘MTM’) services. The company also provides customized management, patient…

FridayMar 24, 2023 11:40 am

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psychedelic Drugs Market

Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. “Silo Pharma has distinguished itself amongst peers for its ground-breaking research into conditions such as post-traumatic stress disorder (‘PTSD’), fibromyalgia, Alzheimer’s disease, and other rare neurological disorders. The company has recently entered into a number of studies designed to develop innovative solutions for previously underserved conditions,” a recent article reads. This comes as a recent study found that psychedelic drugs could show promise as a therapeutic alternative in treating drug-resistant depression. “What the study found was that psychedelics were increasingly able to access…

Site Search

Company Search

Category: QualityStocksNewsBreaks